![]() Eiger BioPharmaceuticals Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis. | ||
Founding Date | Founding Date 2008 | Founding Date 1904 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations Palo Alto, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more |
Employees | Employees 2433% increase | Employees 7,5692% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $15.8m (FY, 2023) | Revenue (est.) $7.9b (FY, 2020) |